Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway
Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Malignant glioma is among the most lethal and frequently occurring brain tumors, and the average survival period is 15 months. Existing chemotherapy has low tolerance and low blood-brain barrier (BBB) permeability; therefore, the required drug dose cannot be accurately delivered to the tumor site, resulting in an insufficient drug effect.
Herein...
Alternative Titles
Full title
Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10271080
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10271080
Other Identifiers
ISSN
2055-7124,1226-4601
E-ISSN
2055-7124
DOI
10.1186/s40824-023-00360-3
